Review
doi: 10.1111/j.1600-0609.1991.tb01265.x.
Autologous bone marrow transplantation for non-Hodgkin's lymphoma
Affiliations
- PMID: 2009945
- DOI: 10.1111/j.1600-0609.1991.tb01265.x
Item in Clipboard
Review
Autologous bone marrow transplantation for non-Hodgkin's lymphoma
Eur J Haematol.
1991 Mar.
Abstract
Autologous bone marrow transplantation (ABMT) is now so widely applied in the treatment of relapsed high- and intermediate-grade non-Hodgkin's lymphoma (NHL) that it is very important to analyse the evidence on which this practice is based and ask in precise terms what the place of this technique should be. This article will review the data that have been published and discuss the randomised studies now in progress. The possible use of ABMT in other areas such as consolidation of remission and its use in low-grade lymphoma will also be examined. The EBMT data quoted are taken from the 1990 review of the register for ABMT in malignant lymphoma which was presented to the XVIth meeting of the EBMT in the Hague in 1990.
Similar articles
-
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma.Ann Oncol. 1994;5 Suppl 2:147-9. doi: 10.1093/annonc/5.suppl_2.s147. Ann Oncol. 1994. PMID: 8204514
-
Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.J Clin Oncol. 1993 May;11(5):931-6. doi: 10.1200/JCO.1993.11.5.931. J Clin Oncol. 1993. PMID: 8487057 Clinical Trial.
-
[Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].Zhonghua Nei Ke Za Zhi. 1992 Oct;30(10):640-2, 660. Zhonghua Nei Ke Za Zhi. 1992. PMID: 1582346 Chinese.
-
Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.Hematol Oncol Clin North Am. 1990 Jun;4(3):577-87. Hematol Oncol Clin North Am. 1990. PMID: 1972701 Review.
-
Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.Hematol Oncol Clin North Am. 1993 Jun;7(3):577-90. Hematol Oncol Clin North Am. 1993. PMID: 8102135 Review.
Cited by
-
Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group.Ann Hematol. 1993 Sep;67(3):111-4. doi: 10.1007/BF01701731. Ann Hematol. 1993. PMID: 8373895
-
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.Br J Cancer. 1997;75(8):1205-12. doi: 10.1038/bjc.1997.206. Br J Cancer. 1997. PMID: 9099971 Free PMC article. Clinical Trial.
-
The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.Mol Biotechnol. 1999 Apr;11(2):181-94. doi: 10.1007/BF02915811. Mol Biotechnol. 1999. PMID: 10464772
-
The role of autografting in lymphoma.Postgrad Med J. 1994 Jul;70(825):475-8. doi: 10.1136/pgmj.70.825.475. Postgrad Med J. 1994. PMID: 7937424 Free PMC article. Review. No abstract available.
-
Intracranial haematomas following bone marrow transplantation.J Neurol. 1994 Feb;241(4):252-6. doi: 10.1007/BF00863777. J Neurol. 1994. PMID: 8195826
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
